95% of Alzheimer’s disease is not inherited. You do not need to have a family member with Alzheimer’s disease to be at risk of developing dementia as you age. During the past fifteen years, abnormalities in mitochondrial structure and function have been identified as a potential trigger and driver of the Alzheimer’s disease process. No drug treatment has yet been identified that slows or halts AD progression. 

I utilize an approach similar to Dr. Dale Bredesen who worked with Nobel laureate Stanley Prusiner’s laboratory and then moved on to perform AD research at UCLA medical school. Dr. Bredesen’s program focuses on reviving brain function through mitochondrial support, improved gut health, hormonal balancing and eliminating environmental toxins.

By delivering a well-studied mitochondrial support program designed to decrease oxidative stress and promote mitochondrial repair, and by simultaneously providing gentle stimulation to the brain, the symptoms of Alzheimer’s disease can often be stabilized and improved. We will perform and follow cognitive testing on a quarterly basis to monitor the effects of this treatment. In mild to moderate cases of Alzheimer’s disease, noticeable improvement can often be demonstrated within 3-4 months.